PT Woori Finance Indonesia Tbk (IDX:BPFI)

Sage Therapeutics Statistics

Total Valuation

IDX:BPFI has a market cap or net worth of IDR 893.11 billion.

Market Cap	893.11B
Enterprise Value	n/a

Important Dates

The last earnings date was Friday, July 25, 2025.

Earnings Date	Jul 25, 2025
Ex-Dividend Date	Jul 7, 2025

Share Statistics

IDX:BPFI has 2.67 billion shares outstanding.

Current Share Class	2.67B
Shares Outstanding	2.67B
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	206.16M

Valuation Ratios

The trailing PE ratio is 10.74.

PE Ratio	10.74
Forward PE	n/a
PS Ratio	2.84
PB Ratio	0.77
P/TBV Ratio	0.77
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 51.99, with a Debt / Equity ratio of 0.81.

Current Ratio	51.99
Quick Ratio	51.60
Debt / Equity	0.81
Debt / EBITDA	n/a
Debt / FCF	-9.11
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is 7.36%.

Return on Equity (ROE)	7.36%
Return on Assets (ROA)	4.06%
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	n/a
Revenue Per Employee	280.05M
Profits Per Employee	74.12M
Employee Count	1,124
Asset Turnover	0.15
Inventory Turnover	n/a

Taxes

In the past 12 months, IDX:BPFI has paid 17.44 billion in taxes.

Income Tax	17.44B
Effective Tax Rate	17.34%

Stock Price Statistics

The stock price has decreased by -3.51% in the last 52 weeks. The beta is 0.30, so IDX:BPFI's price volatility has been lower than the market average.

Beta (5Y)	0.30
52-Week Price Change	-3.51%
50-Day Moving Average	345.24
200-Day Moving Average	317.94
Relative Strength Index (RSI)	41.49
Average Volume (20 Days)	14,265

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, IDX:BPFI had revenue of IDR 314.22 billion and earned 83.16 billion in profits. Earnings per share was 31.10.

Revenue	314.22B
Gross Profit	311.16B
Operating Income	113.05B
Pretax Income	100.60B
Net Income	83.16B
EBITDA	n/a
EBIT	n/a
Earnings Per Share (EPS)	31.10

Balance Sheet

The company has 35.28 billion in cash and 933.27 billion in debt, giving a net cash position of -897.98 billion or -335.82 per share.

Cash & Cash Equivalents	35.28B
Total Debt	933.27B
Net Cash	-897.98B
Net Cash Per Share	-335.82
Equity (Book Value)	1.16T
Book Value Per Share	433.68
Working Capital	1.99T

Cash Flow

In the last 12 months, operating cash flow was -92.04 billion and capital expenditures -10.37 billion, giving a free cash flow of -102.41 billion.

Operating Cash Flow	-92.04B
Capital Expenditures	-10.37B
Free Cash Flow	-102.41B
FCF Per Share	-38.30

Margins

Gross margin is 99.03%, with operating and profit margins of 35.98% and 26.47%.

Gross Margin	99.03%
Operating Margin	35.98%
Pretax Margin	32.02%
Profit Margin	26.47%
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 9.72, which amounts to a dividend yield of 2.96%.

Dividend Per Share	9.72
Dividend Yield	2.96%
Dividend Growth (YoY)	1.75%
Years of Dividend Growth	1
Payout Ratio	31.26%
Buyback Yield	n/a
Shareholder Yield	2.96%
Earnings Yield	9.31%
FCF Yield	-11.47%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on January 31, 2022. It was a forward split with a ratio of 1.5.

Last Split Date	Jan 31, 2022
Split Type	Forward
Split Ratio	1.5

Scores

Altman Z-Score	n/a
Piotroski F-Score	3